News Category
Viromed Medical AG signs distribution agreements for its cold plasma device ViroCAP® in six new markets, expecting at least 3,000 additional device sa...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant step toward a novel neuroprotective therapy for multiple...
PX1 Research introduces US-manufactured sublingual peptide strips, including Retatrutide, Tirzepatide, and BPC-157, for needle-free research applicati...
PX1 Research's new seven-stage HPLC purity verification and cGMP compliance across its US-based peptide manufacturing ensures batch-level documentatio...
NanoViricides received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 in the Democratic Republic of Congo, potentially off...
New research from the University of Virginia suggests focused ultrasound could make brain cancer treatments more effective and less harmful, potential...
Peer-reviewed data demonstrate Telomir-Zn's selective anti-tumor activity in TNBC models, supporting advancement to Phase 1/2 clinical trials.
Park-Ohio's second-quarter results reveal a portfolio inflection with improved margins and raised guidance, indicating the core business is strengthen...
ICON Smile Studios' new flagship campuses in Virginia Beach and Norfolk mark a significant expansion of integrated specialty dental care, continuing a...
Scinai Immunotherapeutics strengthens its CDMO platform with the appointment of Eran Kuratz, a seasoned executive, to oversee supply chain and busines...
The FDA's approval of Quantum BioPharma's IND application for Lucid-MS advances a novel neuroprotective candidate targeting demyelination into Phase 2...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, fueled by $11 million in TONMYA sales, while the company progresses its clinical pipel...
Tonix Pharmaceuticals' Q2 2026 revenue jumped to $13.5 million, driven by TONMYA sales, signaling strong commercial uptake and pipeline progress.
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, propelled by TONMYA's robust sales, signaling strong commercial uptake and a pr...
Voyageur Pharmaceuticals reports successful lab results for its Mueller iodine extraction process, achieving 99.8% purity and >90% recovery, and is se...
OffScript introduces two lines of sublingual nootropic mints with fully disclosed ingredient dosing and third-party testing, addressing consumer deman...
A new narrative review provides a comprehensive clinical framework for tailoring neuroblastoma treatment based on risk factors, emphasizing the import...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through clinical trials and regulatory approvals, positioning it as...
Quantum BioPharma's two-pronged approach, combining its MS therapy Lucid-MS and supplement unbuzzd, highlights a novel strategy that could reshape tre...
Quantum BioPharma's two-pronged approach targets multiple sclerosis through Lucid-MS and alcohol misuse with unbuzzd, potentially offering new therape...
VERAXA Biotech's proprietary BiTAC platform and pipeline of bispecific ADCs and T-cell engagers position it to capitalize on significant pharmaceutica...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer underscores the dangers of undercooked pork and the need for better di...
Veetee USA's appointment of Kevin Stitt signals a strategic push into major US retailers, backed by a planned domestic manufacturing hub, to different...
Lantern Pharma's upcoming webcast on Q2 2026 results will detail financials and updates on its AI-driven oncology pipeline and RADR platform, signalin...
Earth Science Tech's fiscal Q1 2027 results show a 57% net income surge, robust cash flow, and strategic initiatives including share repurchases and p...
Thorium Atomics has initiated pre-application regulatory engagement with the U.S. NRC for its Tesseract TGR advanced reactor, marking a key step in de...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, strength...
American Fusion Inc. has filed six additional U.S. patent applications, bringing its total to 82, and provided updates on regulatory steps and upcomin...
Nanox Imaging secures $8 million through a registered direct offering with a long-term institutional investor, aiming to bolster its preventive health...
A new liquid biopsy offers a simpler way to forecast which advanced lung cancer patients will benefit from immunotherapy, potentially aiding drug deve...
GeoVax's completion of manufacturing, regulatory, and preclinical milestones for its GEO-MVA mpox/smallpox vaccine de-risks the program and paves the ...
Innovative Designs, Inc. announces its best quarter in company history with near 40% revenue growth and its eighth consecutive profitable quarter, hig...
The July Wellness Index Report highlights a paradigm shift in longevity from overriding biology to enhancing the body's natural systems, with implicat...
Regentis Biomaterials' European approval of a next-generation manufacturing process for GelrinC reduces costs and boosts yield, positioning it as a sc...
Purple Exhibits announces Joey Bartman's expanded oversight for all KBIS 2027 projects, ensuring expert guidance and quality control for exhibitors.
Onco-Innovations is leveraging a multi-pronged approach combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI to advance its lead cand...
Earth Science Tech's strategic focus on vertical integration and proprietary technology in telehealth and peptide therapy markets highlights its poten...
Episode 812 of DH Unplugged dissects volatile markets driven by Big Tech earnings, a Korean stock market crash, and a controversial SpaceX post-IPO sl...
Nagoya University researchers discovered that the immune protein C3, when produced by tumor cells, can boost the effectiveness of immunotherapy, offer...
American Fusion's CTO presented the Texatron Fusion Engine program and GEM Unification Theory at the APS DPF 2026 Meeting, advancing the company's vis...
VolitionRx's new Capture-Seq technology isolates pure ctDNA, addressing a major challenge in liquid biopsy and opening doors to multi-cancer early det...
Tonix Pharmaceuticals announced participation in two key investor conferences, providing a platform to discuss its commercial progress and pipeline, w...
VERAXA Biotech's VXA-222 bispecific antibody-drug conjugate advances to the next development stage, supported by an expanded patent portfolio, undersc...
LataMed AI Corp. will participate in an educational conference at Universidad Santa Maria in Caracas to discuss the role of artificial intelligence in...
NeuroThera Labs has initiated its Phase IIb clinical trial for SCI-110 at the Yale Child Study Center, marking a significant step in developing a nove...
Medios AG has appointed Katrin Neuffer to lead its investor relations and communications, a move that underscores the company's commitment to strength...
SRX Global acquires a stake in Vistagen Therapeutics, signaling confidence in the undervalued biopharmaceutical company and potential strategic initia...
SRX Global's acquisition of a stake in Vistagen Therapeutics signals confidence in the undervalued biopharmaceutical company and potential for strateg...
